How Much Did CrossLink Life Sciences Raise?
Funding & Key Investors

CrossLink Life Sciences has solidified its position within the medical device sector, securing a significant capital injection to bolster its operational capabilities. The organization, which has maintained a consistent trajectory of growth, recently finalized a major strategic investment totaling $5M. This latest infusion of capital brings the firm's cumulative financial backing to $5M, underscoring its resilience and long-term viability in the competitive orthopaedic and spine implant market.

CrossLink Life Sciences
ManufacturingMedical Devices & EquipmentRetail

Founded in 1978 and headquartered in Norcross, Georgia, CrossLink Life Sciences operates as a critical intermediary in the healthcare supply chain. The company specializes in the distribution of high-precision orthopaedic and spine implants, serving as a vital link between medical device manufacturers and a vast network of surgeons and healthcare facilities across the United States. By leveraging decades of industry expertise, the firm has established a robust infrastructure that facilitates the delivery of essential surgical technologies, ensuring that medical professionals have reliable access to the tools required for complex spinal and orthopaedic procedures. Its market position is defined by deep-rooted relationships with both clinical practitioners and industrial partners, allowing it to navigate the complexities of the medical device landscape with high operational efficiency.

CrossLink Life Sciences has raised a total of $5M across 1 funding round:

2020

Debt

$5M

Debt (2020): $5M with participation from PPP

PPP

Public-Private Partnership

With the successful acquisition of this major strategic investment, CrossLink Life Sciences is well-positioned to scale its distribution network and enhance its service offerings. The enterprise-level funding suggests a focus on optimizing supply chain logistics and potentially expanding its portfolio of surgical solutions to meet the evolving demands of the orthopaedic sector. As the company moves forward, the focus will likely remain on strengthening its market share through technological integration and deepening its collaborative ties with the surgical community. This capital deployment serves as a foundation for sustained growth, enabling the firm to maintain its competitive edge while addressing the increasing complexity of modern spine and orthopaedic care requirements.

See full CrossLink Life Sciences company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Manufacturing industry

Building MaterialsManufacturingAutomotive PartsReal Estate
ManufacturingPlastic, Packaging & ContainersHousehold Goods
Boats & SubmarinesManufacturingCivil Engineering ConstructionConstruction
Industrial Machinery & EquipmentManufacturing
What are the most recent funding rounds that CrossLink Life Sciences has completed, and what were the funding rounds?
CrossLink Life Sciences has recently completed 1 funding rounds: Debt on Apr 8, 2020.
What is the total amount of funding CrossLink Life Sciences has raised to date?
CrossLink Life Sciences has raised a total of $5M in funding to date.
How many funding rounds has CrossLink Life Sciences completed?
CrossLink Life Sciences has completed 1 funding rounds.
How much funding did CrossLink Life Sciences raise in its most recent funding round?
CrossLink Life Sciences raised $5M in its most recent funding round.
Who are the lead investors in CrossLink Life Sciences's latest funding round?
The lead investor in CrossLink Life Sciences's latest funding round was PPP. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in CrossLink Life Sciences's history?
The largest funding round in CrossLink Life Sciences's history was $5M.
See more information about CrossLink Life Sciences